High-dimensional single-cell definition of CLL T cells identifies Galectin-9 as novel immunotherapy target

Laura Llaó Cid(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Martina Seiffert(German Cancer Research Center), Antonio Cosma(Luxembourg Institute of Health), Andreas Rosenwald(Comprehensive Cancer Center Mainfranken), Elı́as Campo(Hospital Clínic de Barcelona), Margot Chazotte(Heidelberg University), Etienne Moussay(Luxembourg Institute of Health), Susanne Gonder(Luxembourg Institute of Health), JKL Wong(German Cancer Research Center), Marc Zapatka(German Cancer Research Center), Elena Hartmann(University of Würzburg), Sascha Dietrich(European Molecular Biology Organization), A Flörchinger(German Cancer Research Center), Giulia Pagano(Luxembourg Institute of Health), Denis Schapiro(Heidelberg University), Tobias Roider(European Molecular Biology Organization), Dolors Colomer(Hospital Clínic de Barcelona), Marina Wierz(Luxembourg Institute of Health), Murat Iskar(German Cancer Research Center), Iria Fernandez Botana(Luxembourg Institute of Health), Christoph Schifflers(German Cancer Research Center), Felix Czernilofsky(Heidelberg University), Kresimir Bestak(Heidelberg University), Bruch P-M(Heidelberg University), Peter Lichter(German Cancer Research Center), JP Mallm(German Cancer Research Center), Yashna Paul(German Cancer Research Center), DE Campton, Jérôme Paggetti(Luxembourg Institute of Health)
bioRxiv (Cold Spring Harbor Laboratory)
December 16, 2022
Cited by 6


Related Papers